Publications Refereed papers in professional journals
1. Dannon PN, Ianco J, Hirschmann S, Grunhaus L, Zohar J. Cholesterol and
suicidality in major depression: A pilot study. Acta Psychiatrica Belgica 1997: 3;211-219.
2. Stern L. Hirschmann S, Grunhaus L. ECT in patients with major depression
disorder and cardiac output. Convulsive Therapy 1997: 13; 68-73.
3. Grunhaus L, Shiply JE, Eisser A, Pande C, Krahn D, Dimitrach A, Remen S,
Hirschmann S, Greden JF. Sleep onset rapid eye movement (SOREM) : Post ECT is more frequent in patients who respond less electroconvulsive therapy. Biological Psychiatry 1997: 42; 191-200.
4. Dolberg OT, Hirschmann S, Grunhaus L. Melatonin for the treatment of sleep
disturbances in major depressive disorder. American Journal of Psychiatry 1998; 155: 1119-1121.
5. Kindler S, Dolberg OT, Cohen H, Hirschmann S, Kotler M. The treatment of
comorbid premature ejaculation and panic disorder with fluoxetine. Clinical Neuropharmacology 1997: 20; 466-471.
6. Dannon R, Ross P, Hirschmann S, Iancu I, Dolberg OT, Grunhaus Jl. Labetalol
does not lengthen asystole during electrocunvulsive therapy. Journal of Convulsive Therapy, 1998; 14: 245-250
7. Fleischman A, Hirschmann S, Dolberg OT, Grunhaus L. Chronic treatment with
transcranial magnetic stimulation inhibits enzyme induction in rats. Biological Psychiatry 1999; 45:759-763.
8. Stern L, Dannon PN, Hirschmann S, Schriber S, Amytal D, Dolberg OR, Grunhaus
L. Aminophyline increases seizure length during electroconvulsive therapy. Journal of Electroconvulsive Therapy 1999, 15: 252-257.
9. Hirschmann S, Dannon PN, Iancu I, Dolberg OT, Zohar J, Grunhaus L. Pindolol
augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology 2000, 20(5): 556-559.
10. Modai I, Hirschmann S, Rava A, Kurs R, Barak P, Lichtenberg, P., Ritsner M.
Sudden death in patients receiving clozapine treatment: A preliminary investigation. Journal of Clinical Psychopharmacology, 2000, 20(3): 325-327.
11. Dannon PN, Sasson Y, Hirschmann S, Iancu I, Grunhaus LJ, Zohar J. Pindolol
augmentation in treatment resistant obsessive compulsive disorder: a double blind placebo controlled trial. European Neurpsychopharmacology, 2000, 10(3): 165-169.
12. Caspi N, Modai I, Barak P, Waisbourd A, Zbarsky H, Hirschmann S, Ritsner M.
Pindolol augmentation in aggressive schizophrenic patients: a double-blind crossover randomized study. Int Clin Psychopharmacol. 2001 Mar;16(2):111-5.
13. Peled A, Ritsner M, Hirschmann S, Geva AB, Modai I. Touch feel illusion in
schizophrenic patients. Biol Psychiatry. 2000 Dec 1;48(11):1105-8.
14. Segman RH, Shapira Y, Modai I, Hamdan A, Zislin J, Heresco-Levy U, Kanyas K,
Hirschmann S, Karni O, Finkel B, Schlafman M, Lerner A, Shapira B, Macciardi F, Lerer B. Angiotensin converting enzyme gene insertion/deletion polymorphism: case- control association studies in schizophrenia, major affective disorder, and tardive dyskinesia and a family-based association study in schizophrenia. Am J Med Genet. 2002 Apr 8;114(3):310-4.
15. Modai I, Ritsner M, Ponizovsky A, Rivkin O, Bernat C, Gelber D, Ratner Y, Hadjez
J, Kurs R, Hirschmann S. Assessment of suicide risk for psychiatric patients, the impact of prior suicide attempts. Crisis 2002;23(2):47-54.
16. Modai I, Hirschmann S, Hadjez J, Bernat C, Gelber D, Ratner Y, Rivkin O, Kurs R,
Ponizovsky A, Ritsner M. Clinical evaluation of prior suicide attempts and suicide risk in psychiatric inpatients.Crisis. 2002;23(2):47-54.
17. Segman RH, Modai I, Yakir A, Nemanov L, Hirschmann S, Kanyas K, Karni O,
Turetsky N, Macciardi F, Ebstein RP, Lerer B. Linkage disequilibrium studies of schizophrenia with chromosome 1q and chromosome 8p microsatellite markers in Jewish Israeli nuclear families. American Journal of Medical Genetics Am J Med Genet. 2002 Apr 8;114(3):310-4.
18. Ritsner M, Kurs R, Gibel A, Hirschmann S, Shinkarenko E, Ratner Y. Predictors of
Quality fo Life in Major Psychoses: A Naturalistic Follow-Up Study. J Clin Psychiatry 2003; 64: 308-315.
19. Avi Bleich MD, MPA 1,2, Yehuda Baruch MD2,3, Shmuel Hirschmann MD,
MHA, LLB4, Gad Lubin MD5, Yuval Melamed MD, MHA1,2 , Zvi Zemishlany MD 2,6, Ze'ev Kaplan MD7, Management of the suicidal patient in the era of defensive medicine: Focus on suicide risk assessment and boundaries of responsibility The position paper was published in Hebrew in Refuah U'Mishpat (December 2009, 41:46- 50). The English version of the position paper appears in IMAJ with permission of Hebrew publisher.
20. Drach-Zahavy A, Goldblatt H, Granot M, Hirschmann S, Kostintski H. Control:
Patients' Aggression in Psychiatric Settings. Qual Health Res. 2011 Jul 8.
21. Cloninger CR, Zohar AH, Hirschmann S, Dahan D. The psychological costs and
benefits of being highly persistent: Personality profiles distinguish mood disorders from anxiety disorders. J Affect Disord. 2011 Oct 28.
22. Ada H Zohar, Ph.D.; Claude R Cloninger, M.D.; Shmuel Hirschmann, M.D.; Dahan
Dahan, B.A.; Abira Reizer, Ph.D.; Raphael Carel, M.D. Personality and Individual Differences Title: Type D and Temperament and Character Personality Profiles:
Association with Emotional, Mental, and Physical Health in a Non-Clinical Community Sample: submitted
23. Hirschmann S, Weizman R, Apter A. Adolescent Suicide. Harefuah Vol. 126,
24. Hirschmann S, Dolberg TO, Stein L, Grunhaus JL. Valproic acid for borderline
personality disorder. Harefuah Vol. 133 (5-6): 205-208, 1997.
25. Dannon PN, Ianco J, Hirschmann S, Sasson Y, Zohar J. The emergence of
kleptomania with SSRI’s. Psychiatric Review, 1997.
26. Hirschmann S, תיטרפה הקינילקב תננוגתמ האופרו תונדבוא Psychiatry Up-dates. And
27. Hirschmann S, ירשפ
א -למשח יעזנב יופכ לופיט:תינכדע הקיספ Psychiatry Up-dates. And
28. Hirschmann S, ןלשרה הלוחב לופיטה וא לופיטל תונעיה רסוחב אפורה תוירחא Psychiatry Up- dates. And reviews Aprir 2009Case Reports
29. Hirschmann S, Apter A, Weizman A, Redwan M. Anorexia Nervosa beginning
after menopause. Harefuah 131: 10-12, 1996;.
30. Hirschmann S, Apter A, Weizmann A, Radwan M. Anorexia Nervosa beginning
after menopause. Practical Cases on Menopause 1997 8-9 (translation of paper published in Harefuah 1996; 131: 10-12.)
31. Hendler T, Gross R, Goshen E, Faibel M, Hirschmann S, Bakun M, Ram Z, Lustig
M, Zwass T, Grunhaus JL, Zohar J. Brain imaging and its clinical application in psychiatry. Harefuah. Vol 133 (9): 337-342, 1997.
32. Ravona-Springer R, Dolberg TO, Hirschmann S, Grunhaus JL. Behavioral Toxicity
in elderly patients treated with risperidone - A report of three cases. Journal of Clinical Psychopharmacology, 18;171-172, 1998.
33. Nacasch N, Dolberg OT, Hirschmann S, Dannon P, Grunhaus LJ. Clozapine for the
treatment of agitated-depressed patients with cognitive impairment: a report of three cases. Clinical Neuopharmacology 1998: 21; 132-134.
34. Bogelman G, Hirschmann S, Modai I. Olanzapine and Huntington's Disease. J Clin Psychopharmacol. 2001 Apr;21(2):245-6.
35. Madeb R, Hirschmann S, Kurs R, Turkie A, Modai I. Combined clozapine and
valproic acid treatment-induced agranulocytosis. Eur Psychiatry. 2002 Jul;17(4):238.
Law and Medicine Journal committer-
36. תולכתסה שפנה תואירבב יגולויבו יפרתוכיס
37. תורעה רמאמל לופיט יאופר יופכ – יתמ? לעו ידי ימ? ן
Interactions between national housing policies and legislation, directives, initiatives, programmes and decisions of the European Union An overview for the 15th EU Housing Ministers Conference, to be held in Italy, Rome from 30-31 October 2003 COUNTRY : FINLAND Person responsible for the questionnaire Contact person Ministry / organisation: Ministry of theEnvironmentAddr
Erectile Dysfunction and Constructs of Masculinity and Quality of Life in the Multinational Men’s Attitudes to Life Events and Sexuality (MALES) Study Michael S. Sand, PhD, MPH,* William Fisher, PhD,† Raymond Rosen, PhD,‡ Julia Heiman, PhD,§ andIan Eardley, MD¶*Bayer Schering Pharma AG, Wuppertal, Germany; †University of Western Ontario, London, Ontario, Canada;‡New England Researc